{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:35:31Z","timestamp":1788798931476,"version":"build-2803163510"},"reference-count":24,"publisher":"Scientific Scholar","issue":"02","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South Asian J Cancer"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>Background\u2003Multiple myeloma is a cytogenetically heterogeneous, evolving, and incurable disease. Differences in prevalence of myeloma already exist in Indian subcontinent as compared with Western world countries. This study attempts to investigate differences in incidence of cytogenetic abnormalities (CA) in Eastern Indian patients and study differences in incidence with respect to age and gender.<\/jats:p>\n                  <jats:p>Materials and Methods\u2003Interphase fluorescence in situ hybridization (FISH) was applied on purified plasma cells of 280 newly diagnosed myeloma cases using specific probes.<\/jats:p>\n                  <jats:p>Statistical Analysis\u2003Data was analyzed using SPSS software version 25.<\/jats:p>\n                  <jats:p>Results\u2003Note that 51.07% patients were FISH positive. Del13q was the most common CA. Significant association of del 13q with t(4;14), del 17p, and gain of 1q was seen. The frequencies of FISH positive and negative groups differed in the different age groups; higher number of cases in 41 to 50 years group in FISH positive group (p\u2009&lt;\u20090.05) and lower number of cases in FISH positive group in 61 to 70 years (p\u2009&lt;\u20090.05) as compared with FISH negative group. Del 17p had higher number of cases in age group 41 to 50 years and 51 to 60 years as compared with other age groups. Incidence of t(11;14) was in 5th to 7th decade while del 13q and t(4;14) had the widest range of age at presentation. Gender disparities were seen in high-risk cytogenetics like del 17p and 1q gain.<\/jats:p>\n                  <jats:p>Conclusion\u2003The differences in incidence rate of CAs per se in myeloma cases diagnosed in Indian subcontinent and the differences in incidence with respect to age and gender warrant further multicentric studies.<\/jats:p>","DOI":"10.1055\/s-0043-1761441","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T19:47:25Z","timestamp":1707767245000},"page":"126-131","source":"Crossref","is-referenced-by-count":1,"title":["Cytogenetic Alterations and Correlation with Age and Gender in Patients of Multiple Myeloma: A Study from a Tertiary Care Center in Eastern India"],"prefix":"10.25259","volume":"13","author":[{"given":"Karuna","family":"Jha","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology, Institute of Hematology and Transfusion Medicine, Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-6373","authenticated-orcid":false,"given":"Sandeep","family":"Saha","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology, Institute of Hematology and Transfusion Medicine, Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6984-168X","authenticated-orcid":false,"given":"Maitreyee","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology, Institute of Hematology and Transfusion Medicine, Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"864058","DOI":"10.1155\/2014\/864058","article-title":"The genetic architecture of multiple myeloma","volume":"2014","author":"S M Prideaux","year":"2014","journal-title":"Adv Hematol"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1179\/102453309X385250","article-title":"Fluorescent in situ hybridization studies in multiple myeloma","volume":"14","author":"O O Yuregir","year":"2009","journal-title":"Hematology"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group molecular classification of multiple myeloma: spotlight review","volume":"23","author":"R Fonseca","year":"2009","journal-title":"Leukemia"},{"issue":"11","key":"ref4","first-page":"1455","article-title":"Frequency and prognostic value of chromosome abnormalities in multiple myeloma [in Japanese]","volume":"48","author":"S Kurahashi","year":"2007","journal-title":"Rinsho Ketsueki"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5045\/br.2016.51.2.122","article-title":"A retrospective analysis of cytogenetic alterations in patients with newly diagnosed multiple myeloma: a single center study in Korea","volume":"51","author":"S Li","year":"2016","journal-title":"Blood Res"},{"issue":"09","key":"ref6","doi-asserted-by":"crossref","first-page":"e1363","DOI":"10.1002\/mgg3.1363","article-title":"Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients","volume":"8","author":"H Hamdaoui","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"09","key":"ref7","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/annonc\/mdi273","article-title":"Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan","volume":"16","author":"S Y Huang","year":"2005","journal-title":"Ann Oncol"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-020-00348-5","article-title":"Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response","volume":"10","author":"N Abdallah","year":"2020","journal-title":"Blood Cancer J"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/leu.2013.258","article-title":"Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma","volume":"28","author":"A J Greenberg","year":"2014","journal-title":"Leukemia"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.30699\/ijp.2020.105128.2078","article-title":"Cytogenetics and Revised International Staging System (R-ISS): risk stratification in multiple myeloma - a retrospective study in Indian population","volume":"15","author":"C BK Udupa","year":"2020","journal-title":"Iran J Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/ami.ami_42_18","article-title":"Chromosomal aberrations in multiple myeloma: a study on Indian population","volume":"5","author":"A P Royal","year":"2018","journal-title":"Acta Med Int"},{"issue":"22","key":"ref12","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1182\/blood.V128.22.5646.5646","article-title":"FISH Analysis in Multiple Myeloma - a Retrospective Study from India","volume":"128","author":"P Dhiman","year":"2016","journal-title":"Blood"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.31557\/APJCP.2019.20.1.235","article-title":"Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India","volume":"20","author":"P Govindasamy","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"issue":"04","key":"ref14","first-page":"536","article-title":"Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India","volume":"144","author":"P S Kadam Amare","year":"2016","journal-title":"Indian J Med Res"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41408-019-0191-y","article-title":"Natural history of multiple myeloma with de novo del(17p)","volume":"9","author":"A Lakshman","year":"2019","journal-title":"Blood Cancer J"},{"issue":"01","key":"ref16","first-page":"1","article-title":"Cytogenetics and FISH studies in multiple myeloma-a retrospective study from Western India","volume":"2","author":"P K Gadhia","year":"2015","journal-title":"Am J Curr Biol"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/cells10020336","article-title":"Genetic abnormalities in multiple myeloma: prognostic and therapeutic implications","volume":"10","author":"I J Cardona-Benavides","year":"2021","journal-title":"Cells"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"R A Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"08","key":"ref19","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1158\/1055-9965.EPI-11-0157","article-title":"Gender disparities in the tumor genetics and clinical outcome of multiple myeloma","volume":"20","author":"K D Boyd","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2002-10-3017","article-title":"Clinical and biologic implications of recurrent genomic aberrations in myeloma","volume":"101","author":"R Fonseca","year":"2003","journal-title":"Blood"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/sj.leu.2403153","article-title":"High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis","volume":"17","author":"P Liebisch","year":"2003","journal-title":"Leukemia"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-4608(94)00284-I","article-title":"Cytogenetic findings in 200 patients with multiple myeloma","volume":"82","author":"J R Sawyer","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.2006.06481.x","article-title":"Abnormalities of chromosome 1p\/q are highly associated with chromosome 13\/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma","volume":"136","author":"K L Wu","year":"2007","journal-title":"Br J Haematol"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41408-019-0254-0","article-title":"Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone","volume":"9","author":"T M Schmidt","year":"2019","journal-title":"Blood Cancer J"}],"container-title":["South Asian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1761441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:12:53Z","timestamp":1781176373000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.sajc.org\/cytogenetic-alterations-and-correlation-with-age-and-gender-in-patients-of-multiple-myeloma-a-study-from-a-tertiary-care-center-in-eastern-india\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":24,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,6,24]]},"published-print":{"date-parts":[[2024,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1761441","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2278-330X","2278-4306"],"issn-type":[{"value":"2278-330X","type":"print"},{"value":"2278-4306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]}}}